Bifidobacterium breve strain N6D12 C1090

Bifidobacterium breve strain N6D12 C1090 is a Gram-positive, anaerobic bacterium characterized by its rod shape and the presence of flagella. This strain is notable for its habitat, primarily residing in human breast milk and the gastrointestinal tract, particularly within the gut microbiota of healthy newborns. It plays a significant role in the infant intestine, contributing to the development of a healthy gut microbiome during early life. Bifidobacterium breve is nonsporulating and possesses a single replicon, which is indicative of its cellular organization and replication mechanism. Its presence in human breast milk suggests a potential for beneficial effects on infant health, as breast milk is known to be a primary source of nutrients and microbial colonizers for newborns. The dominance of Bifidobacterium species, including B. breve, in the gut microbiota of infants highlights the importance of these bacteria in establishing a balanced microbial community that can influence immune development and metabolic processes. The ecological insight derived from the distribution of Bifidobacterium breve in breast milk and the infant gut underscores the critical role of maternal health and nutrition in shaping the early microbiota of infants. This relationship suggests that breastfeeding may provide essential microbial inoculation, which is crucial for the formation of a healthy gut ecosystem in newborns. Accessions for this strain are cataloged under NJOA00000000.1, facilitating further research into its properties and potential applications in probiotic development.